Prion protein disease and neuropathology of prion disease

被引:9
|
作者
du Plessis, Daniel G. [1 ,2 ]
机构
[1] Salford Royal Hosp, Neuropathol Unit, Dept Cellular Pathol, Salford M6 8HD, Lancs, England
[2] Salford Royal Hosp, Greater Manchester Neurosci Ctr, Salford M6 8HD, Lancs, England
关键词
D O I
10.1016/j.nic.2007.12.003
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Human prion diseases, in common with other neurodegenerative diseases, may be sporadic or inherited and are characterized by the accumulation of cellular proteins accompanied by neuronal death and synaptic loss. Prion diseases are, however, unique in being transmissible. Central to the pathogenesis of all forms of prion disease is the prion protein. This article provides a brief overview of the biology of human prion diseases followed by a more in-depth discussion of the neuropathology of these diseases, including features of neuroradiologic relevance.
引用
下载
收藏
页码:163 / +
页数:21
相关论文
共 50 条
  • [31] PRION DISEASE
    JOHNSON, RT
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (07): : 486 - 487
  • [32] Prion Disease
    Baldwin, Kelly J.
    Correll, Cynthia M.
    SEMINARS IN NEUROLOGY, 2019, 39 (04) : 428 - 439
  • [33] A naturally occurring variant of the human prion protein completely prevents prion disease
    Emmanuel A. Asante
    Michelle Smidak
    Andrew Grimshaw
    Richard Houghton
    Andrew Tomlinson
    Asif Jeelani
    Tatiana Jakubcova
    Shyma Hamdan
    Angela Richard-Londt
    Jacqueline M. Linehan
    Sebastian Brandner
    Michael Alpers
    Jerome Whitfield
    Simon Mead
    Jonathan D. F. Wadsworth
    John Collinge
    Nature, 2015, 522 : 478 - 481
  • [34] Prion protein lowering is a disease-modifying therapy across prion disease stages, strains and endpoints
    Minikel, Eric Vallabh
    Zhao, Hien T.
    Le, Jason
    O'Moore, Jill
    Pitstick, Rose
    Graffam, Samantha
    Carlson, George A.
    Kavanaugh, Michael P.
    Kriz, Jasna
    Kim, Jae Beom
    Ma, Jiyan
    Wille, Holger
    Aiken, Judd
    McKenzie, Deborah
    Doh-Ura, Katsumi
    Beck, Matthew
    O'Keefe, Rhonda
    Stathopoulos, Jacquelyn
    Caron, Tyler
    Schreiber, Stuart L.
    Carroll, Jeffrey B.
    Kordasiewicz, Holly B.
    Cabin, Deborah E.
    Vallabh, Sonia M.
    NUCLEIC ACIDS RESEARCH, 2020, 48 (19) : 10615 - 10631
  • [35] Soluble dimeric prion protein binds PrPSc in vivo and antagonizes prion disease
    Meier, P
    Genoud, N
    Prinz, M
    Maissen, M
    Rülicke, T
    Zurbriggen, A
    Raeber, AJ
    Aguzzi, A
    CELL, 2003, 113 (01) : 49 - 60
  • [36] Development of oligomeric prion-protein aggregates in a mouse model of prion disease
    Sasaki, Kensuke
    Minaki, Haruhiko
    Iwaki, Toru
    JOURNAL OF PATHOLOGY, 2009, 219 (01): : 123 - 130
  • [37] Neuropathology of prion diseases
    Budka, H
    BRITISH MEDICAL BULLETIN, 2003, 66 : 121 - +
  • [38] NEUROPATHOLOGY OF PRION DISEASES
    PRUSINER, SB
    DEARMOND, SJ
    BRAIN PATHOLOGY, 1995, 5 (01) : 25 - 25
  • [39] A naturally occurring variant of the human prion protein completely prevents prion disease
    Asante, Emmanuel A.
    Smidak, Michelle
    Grimshaw, Andrew
    Houghton, Richard
    Tomlinson, Andrew
    Jeelani, Asif
    Jakubcova, Tatiana
    Hamdan, Shyma
    Richard-Londt, Angela
    Linehan, Jacqueline M.
    Brandner, Sebastian
    Alpers, Michael
    Whitfield, Jerome
    Mead, Simon
    Wadsworth, Jonathan D. F.
    Collinge, John
    NATURE, 2015, 522 (7557) : 478 - +
  • [40] Doxycycline control of prion protein transgene expression modulates prion disease in mice
    Tremblay, P
    Meiner, Z
    Galou, M
    Heinrich, C
    Petromilli, C
    Lisse, T
    Cayetano, J
    Torchia, V
    Mobley, W
    Bujard, H
    DeArmond, SJ
    Prusiner, SB
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) : 12580 - 12585